Brief: Ipsen Completes Acquisition Of Memo Therapeutics
22/07/2026 06:01
BRIEF-Ipsen Completes Acquisition Of Memo Therapeutics July 22 (Reuters) - Ipsen SA IPN.PA:
COMPLETES ACQUISITION OF MEMO THERAPEUTICS AG, ADDING FIRST-IN-CLASS ASSET TO IPSEN'S RARE DISEASE PIPELINE
Source text: ID:nGNEbRt3Ff
Further company coverage: IPN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ipsen SA
See all newsHealth Rounds: New blood test matches gold standard for liver disease diagnosis
Brief: Ipsen Late-Breaking Data Raises Ambitions In PBC
Brief: Charles River Laboratories International Virtual Control Group To Be Used In Glp Study For Ipsen
Pharming shares rise after preliminary Q3 revenue beat
France's Ipsen Q3 sales rise 28% driven by core portfolio